Gannet BioChem
Huntsville, Alabama, United States
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (6)
○ EMA GMP
○ MHRA GMP
Quick Facts: Gannet BioChem
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Huntsville, Alabama, United States
- Website
- https://www.gannetbiochem.com/
- Modalities
- ADC / Bioconjugation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Gannet BioChem
Gannet BioChem is a contract development and manufacturing organization (CDMO). Capabilities: ADC / Bioconjugation. 2 manufacturing sites registered with the U.S. FDA: Huntsville and Arab, Alabama (Laysan Bio, acquired in 2026). Website: https://www.gannetbiochem.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Company Signals 6 articles
Company announcements, not verified evidence. They do not change any score.
Gannet BioChem Fills Key Executive Leadership Positions - Contract Pharma
Gannet BioChem Files Type II Drug Master File for mPEG Propionaldehyde 20K to Support Pegfilgrastim Biosimilars - GlobeNewswire
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities - GlobeNewswire
Gannet BioChem Advances Sustainability Goals Through TVA EnergyRight Strategic Energy Management Program - GlobeNewswire
Nektar Therapeutics’ reagent manufacturing business sold, branded as Gannet BioChem - 256 Today
Ampersand Capital Partners Completes Acquisition of Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem - PR Newswire
Frequently Asked Questions About Gannet BioChem
Does Gannet BioChem have a CDMO Signal Score?
Not yet. Gannet BioChem is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Gannet BioChem for a manufacturing program?
Use the free AI matchmaker to compare Gannet BioChem against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Sterling Pharma Solutions
Cramlington, United Kingdom
Small Molecule API, High-Potency APIs, Peptides, ADC / Bioconjugation, Controlled Substances, Clinical Trial Manufacturing
Veranova
United States
Small Molecule API, ADC / Bioconjugation
AbbVie Contract Manufacturing
North Chicago, Illinois, United States
Small Molecule API, High-Potency APIs, Biologics, ADC / Bioconjugation, Sterile Fill-Finish, Lyophilization, Prefilled Syringes, Oral Solid Dose, Hot-Melt Extrusion, Oral Liquids, Topicals
Olon
Rodano (Milano), Italy
Small Molecule API, Biologics, ADC / Bioconjugation
CARBOGEN AMCIS
Bubendorf, Switzerland
Small Molecule API, ADC / Bioconjugation, Sterile Fill-Finish
Compare Gannet BioChem with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.